Latest News for: cdk4
Edit
Zhonghan Biotech’s Abemaciclib Intermediates: High-Quality Key Intermediates Empowering Efficient Synthesis of CDK4/6 Inhibitors
GetNews 18 Mar 2026
As an orally highly selective, Abemaciclib is a core targeted drug for the treatment of HR+/HER2- breast cancer, widely used in the clinical treatment of locally advanced and metastatic breast cancer ... Jinan Zhonghan Chemical Technology Co., Ltd ... CAS.
- 1